Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy
oleh: Elisa Meucci, Anna Radice, Filippo Fassio, Maria Loredana Chiara Iorno, Donatella Macchia
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2021-10-01 |
Deskripsi
Abstract Anaphylaxis after mosquito bite is rare, but life threatening. No approved preventive therapy is available to date, but omalizumab could be a promising therapeutic option for reducing risk and improving quality of life in these patients.